CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study-Reference-Cited by-同舟云学术

CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study

Published:2017-11-13 Issue:1 Volume:58 Page:78-87
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Domínguez Clara¹^ORCID,Vieites-Prado Alba²,Pérez-Mato María²,Sobrino Tomás²,Rodríguez-Osorio Xiana¹,López Ana¹,Campos Francisco²,Martínez Francisco¹,Castillo José²,Leira Rogelio¹

Affiliation:

1. Department of Neurology, Hospital Clínico Universitario; Universidade de Santiago de Compostela; Santiago de Compostela Spain

2. Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS); Hospital Clínico Universitario, Universidade de Santiago de Compostela; Santiago de Compostela Spain

Funder

Spanish Ministry of Economy and Competitiveness - Instituto de Salud Carlos III

Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS

Xunta de Galicia

FEDER

Miguel Servet Program of Instituto de Salud Carlos III

Fellowship (FPI) from the Spanish Ministry of Economy and Competitiveness

Secretaría de Estado de Investigacion, Desarrollo e Innovacion

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia

Publisher

Wiley

Subject